Second swine flu jab is approved

The swine flu vaccine developed by drug firm Baxter has been given the green light for approval by the European Medicines Agency (EMEA).

The EMEA has granted a 'positive opinion' for Baxter's Celvapan H1N1 pandemic vaccine. It now needs final marketing authorisation by the European Commission before being made available.

The UK government has contracts to buy swine flu vaccine from GSK and Baxter. The GSK vaccine Pandemrix received a 'positive opinion' last month.

England's CMO Sir Liam Donaldson said last week that the vaccination programme would start in the second half of October 'if all goes to plan'.

This would depend on manufacturers' ability to deliver predicted supplies, he said.

Professor David Salisbury, DoH director for immunisation, explained that stock had to go through a process of inventory checking, packing and transporting that would take several days. Vaccines would be distributed on a rolling basis to acute trusts and PCTs.

'We cannot supply every GP in the country simultaneously with a box,' he said. There will have to be a rolling distribution. It will all be driven by the flow in of vaccine.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

UK COVID-19 alert level raised as GPs prioritised for testing

UK COVID-19 alert level raised as GPs prioritised for testing

The government has raised the UK's COVID-19 alert level to four amid reports that...

UK on course for 50,000 COVID-19 cases a day by mid-October

UK on course for 50,000 COVID-19 cases a day by mid-October

The UK could see 50,000 COVID-19 cases per day by mid-October, with the epidemic...

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

Stricter short-term COVID-19 measures needed to avoid second national lockdown, BMA warns

COVID-19 infection rates will ‘soar’ and the NHS will ‘once again be crippled’ if...

Practices handed one-month opt-out window as revamped network DES unveiled

Practices handed one-month opt-out window as revamped network DES unveiled

NHS England has unveiled a revamped DES package for 2020/21 confirming new targets,...

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered huge rise in face-to-face consultations in week before NHS England letter

GPs delivered a huge increase in face-to-face appointments in the week before NHS...

RCGP facing legal action over stance on assisted dying

RCGP facing legal action over stance on assisted dying

The RCGP is facing legal action over its decision to remain opposed to assisted dying...